Clinical Trials Logo

Foetal Growth Problem clinical trials

View clinical trials related to Foetal Growth Problem.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT01734447 Completed - Clinical trials for Small for Gestational Age

Long Term Effect of Somatropin in Subjects With Intrauterine Growth Retardation

Start date: April 30, 2000
Phase: Phase 4
Study type: Interventional

This trial is conducted in Europe. The aim of this trial is to assess the safety of long-term growth hormone treatment in growth-retarded children with intrauterine growth retardation (IUGR) enrolled in trial GHRETARD/F/1/F.

NCT ID: NCT01697644 Completed - Clinical trials for Small for Gestational Age

Growth Hormone Treatment of Children Diagnosed of Intrauterine Growth Retardation

Start date: October 1990
Phase: Phase 4
Study type: Interventional

This trial is conducted in Europe. The aim of this trial is to assess and compare the efficacy and safety of two dose levels of somatropin over a long period (till final height is reached). This trial is an extension to trials GHRETARD/BDP/14/NL (a 2-year initial trial) and GHRETARD/BPD/20/NL (a 2-year extension trial).

NCT ID: NCT01543867 Completed - Turner Syndrome Clinical Trials

Safety and Efficacy of Long-term Somatropin Treatment in Children

GrowthWIN II
Start date: January 2001
Phase: N/A
Study type: Observational

This study is conducted in Europe. The aim of this study is to evaluate safety during the long-term use of somatropin (Norditropin®) in children as well as efficacy on change in height. A subgroup of children small for their gestational age is included.

NCT ID: NCT01327924 Completed - Clinical trials for Chronic Kidney Disease

Usability and Tolerability of the Norditropin NordiFlex® Injection Device in Children Never Previously Treated With Growth Hormone

Start date: April 2011
Phase: N/A
Study type: Observational

This study is conducted in Europe. The purpose of this study is to assess the impact on daily life for children new to using a growth hormone injection device.

NCT ID: NCT01245374 Completed - Clinical trials for Chronic Kidney Disease

Norditropin NordiFlex® Device Compared to the Device Previously Used by Patients or Parents

Start date: November 2010
Phase: Phase 4
Study type: Interventional

This study is conducted in Europe. The aim of this study is to compare the easiness of use of Norditropin NordiFlex® device to the device previously used by patients or parents.

NCT ID: NCT01110928 Completed - Clinical trials for Small for Gestational Age

Observational Study of the Safety and Efficacy of Norditropin® in Patients With SGA (Small for Gestational Age) Short Stature That Are Still Growing

Start date: November 26, 2009
Phase:
Study type: Observational

This study is conducted in Japan. The aim of this observational study is to collect information about the safety and efficacy of Norditropin® in the long-term treatment of patients with a SGA (small for gestational age) short stature where the growth plate in the long bones (epiphyseal disc) is not closed. An extension to the GHLIQUID-1517 trial (NCT00184717).

NCT ID: NCT00960128 Completed - Clinical trials for Chronic Kidney Disease

Observational Prospective Study on Patients Treated With Norditropin®

Start date: April 1, 2006
Phase: N/A
Study type: Observational

This observational study is conducted globally. The aim of the study is to investigate the effectiveness and safety of real-life treatment with Norditropin®. The study population will consist of children and adults who are on treatment with Norditropin® in accordance with normal clinical practice.

NCT ID: NCT00787878 Completed - Clinical trials for Small for Gestational Age

Long Term Metabolic Safety of Norditropin® Treatment of Small for Gestational Age (SGA) Subjects

Start date: February 2009
Phase: Phase 3
Study type: Observational

The study is conducted in Europe. The primary aim of this observational study is to compare the insulin sensitivity in small for gestational age (SGA) subjects treated with Norditropin® with untreated small for gestational age (SGA) subjects and with average for gestational age (AGA) subjects.

NCT ID: NCT00557336 Completed - Clinical trials for Small for Gestational Age

Efficacy and Safety of Growth Hormone Treatment in Children Small for Gestational Age

Start date: July 28, 2003
Phase: Phase 3
Study type: Interventional

This trial is conducted in Europe. The aim of this clinical trial is to evaluate the height gain during 12 months of growth hormone treatment in children born small for gestational age due to intrauterine growth retardation.

NCT ID: NCT00519844 Completed - Clinical trials for Small for Gestational Age

Growth Hormone Treatment in Children Born Small for Gestational Age: Assessment of Satisfaction

Start date: July 2005
Phase: Phase 4
Study type: Interventional

This trial is conducted in Europe. The aim of this trial is to assess satisfaction with growth hormone treatment in children of both sexes born small for gestational age and who are receiving growth hormone treatment.